Mean platelet volume is increased in patients with severe obstructive sleep apnea

References

• Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults N Engl J Med 1993;328;1230–35.
   PubMed Web of Science ®Google Scholar
• Lattimore JD, Celermajer DS, Wilcow I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 2003;41:1429–37.
   PubMed Web of Science ®Google Scholar
• Malone S, Liu PP, Holloway R, Rutherford R, Xie A, Bradley TD. Obstructive sleep apnea in patients with dilated cardiomyopathy: effects of CPAP. Lancet 1991;338:1480–4.
   PubMed Web of Science ®Google Scholar
• Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990;336:261–4.
   PubMed Web of Science ®Google Scholar
• Guilleminault C, Connoly S, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983;52:490–4.
   PubMed Web of Science ®Google Scholar
• Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG. Association of sleep disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study JAMA 2000;283:1829–36.
   Google Scholar
• Weitzenblum E, Krieger J, Apprill M, Vallee E, Ehrhart M, Ratomaharo J, Oswald M, Kurtz D. Daytime pulmonary hypertension in patients with obstructive sleep apnea. Am Rev Respir Dis 1988;138:345–9.
   PubMed Web of Science ®Google Scholar
• Palomaki H, Partinen M, Erkinjuntti I, Kaste M. Snoring, sleep apnea syndrome and stroke. Neurology 1992;42:75–82.
   PubMed Web of Science ®Google Scholar
• Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003;9:177–90.
   PubMed Web of Science ®Google Scholar
• Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 1995;108:625–30.
   PubMed Web of Science ®Google Scholar
• Eisensehr I, Ehrenberg BL, Noachtar S, Korbett K, Byrne A, McAuley A, Palabrica T. Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology 1998;51:188–95.
   PubMed Web of Science ®Google Scholar
• Geiser T, Buck F, Meyer BJ, Bassetti C, Haeberli A, Gugger M. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 2002;69:229–34.
   PubMed Web of Science ®Google Scholar
• von Kanel R, Dimsdale JE. Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 2003;124:1956–67.
   PubMed Web of Science ®Google Scholar
• Hui DS, Ko FW, Fok JP, Chan MC, Li TS, Tomlinson B, Cheng G. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 2004;125:1768–75.
   PubMed Web of Science ®Google Scholar
• Akinnusi ME, Paasch LL, Szarpa KR, Wallace PK, El Solh AA. Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea. Respiration 2009;77:25–31.
   PubMed Web of Science ®Google Scholar
• Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Oda N, Tanaka A, Yamamoto M, Ohta S, O'Donnell CP, Adachi M. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 2007;175:612–7.
   PubMed Web of Science ®Google Scholar
• Park Y, Schoene N, Haris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002;13:301–6.
   PubMed Web of Science ®Google Scholar
• Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003;9:177–90.
   PubMed Web of Science ®Google Scholar
• Martin JF. Platelet heterogeneity in vascular disease. Martin JF, Trowbridge EA Platelet heterogeneity: biology and pathology. Springer-Verlag, London, 1990; 205–26.
   Google Scholar
• Martin JF, Trowbridge EA, Salmon GL, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983;32:443–60.
   PubMed Web of Science ®Google Scholar
• Jakubowski JA, Thompson CB, Vaillancourt R, Valeri CR, Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol 1983;5:503–11.
   Web of Science ®Google Scholar
• Giles H, Smith REA, Martin JF. Platelet glycoprotein IIb–IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 1994;24:69–72.
   PubMed Web of Science ®Google Scholar
• Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 2009;63:1509–15.
   PubMed Web of Science ®Google Scholar
• Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages in human subjects. Los Angeles, CA: Brain Information Service, VCLA 1968.
   Google Scholar
• American Academy of Sleep Medicine Task Force. Sleep related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667–89.
   PubMed Web of Science ®Google Scholar
• Rangemark C, Hedner JA, Carlson JT, Gleer up G, Winther K. Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. Sleep 1995;18:188–94.
   PubMed Web of Science ®Google Scholar
• Sanner BM, Konermann M, Tepel M, Groetz J, Mummenhoff C, Zidek W. Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000;16:648–52.
   PubMed Web of Science ®Google Scholar
• Oga T, Chin K, Tabuchi A, Kawato M, Morimoto T, Takahashi K, Handa T, Takahashi K, Taniguchi R, Kondo H, Mishima M, Kita T, Horiuchi H. Effects of obstructive sleep apnea with intermittent hypoxia on platelet aggregability. J Atheroscler Thromb 2009;16:862–9.
   PubMed Web of Science ®Google Scholar
• Ziegler MG, Nelesen R, Mills P, Ancoli-Israel S, Kennedy B, Dimsdale JE. Sleep apnea, norepinephrine release rate, and daytime hypertension. Sleep 1997;20:224–31.
   PubMed Web of Science ®Google Scholar
• Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897–904.
   PubMed Web of Science ®Google Scholar
• Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 1994;89:1951–7.
   PubMed Web of Science ®Google Scholar
• Von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000;65:357–69.
   PubMed Web of Science ®Google Scholar
• Dunleavy M, Dooley M, Cox D, Bradford A. Chronic intermittent asphyxia increases platelet reactivity in rats. Exp Physiol 2005;90:411–6.
   PubMed Web of Science ®Google Scholar
• Debili N, Masse JM, Katz A, Guichard J, Breton-Gorius J, Vainchenker W. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34s cells. Blood 1993; 82:84–95.
   PubMed Web of Science ®Google Scholar
• Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M. Elevated levels of Creactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129–34.
   PubMed Web of Science ®Google Scholar
• Tauman R, O'Brien LM, Gozal D. Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing. Sleep Breath 2007;11:77–84.
   PubMed Web of Science ®Google Scholar
• Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2005;59:981–2.
   PubMed Web of Science ®Google Scholar
• Eder K, Baffy N, Falus A, Fulop AK. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res 2009; 58:727–36.
   PubMed Web of Science ®Google Scholar
• Anfossi G, Russo I, Trovati M. Platelet dysfunction in central obesity. Nutr Metab Cardiovasc Dis 2009;19:440–9.
   PubMed Web of Science ®Google Scholar